Showing results (281-290 of 295) with videos related to
Sort By:
Pageof 30
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromesSumanta Barman, Saskia Räuber, Katharina Eisenhut, et al.Med (New York, N.Y.)|January 24, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitorsNicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, et al.Nature Immunology|April 24, 2023
High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicityNicolás Gonzalo Nuñez, Jonas Schmid, Laura Power, et al.Nature Communications|January 10, 2024
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host diseaseKristina Maas-Bauer, Anna-Verena Stell, Kai-Li Yan, et al.Blood|July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulationJenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.American Journal of Respiratory and Critical Care Medicine|April 16, 2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint BlockadeNina Wyss, Fiamma Berner, Vincent Walter, et al.Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.Pageof 30